Search research articles
Contact Us
Filters
Showing results (111-120 of 117) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 117 results.
Cancer Cell
|
March 15, 2024
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness
Chun-Pu Lin, Pierre L Levy, Astrid Alflen, et al.
Nature Reviews. Cancer
|
January 21, 2017
Interrogating open issues in cancer precision medicine with patient-derived xenografts
Annette T Byrne, Denis G Alférez, Frédéric Amant, et al.
Nature Reviews. Cancer
|
September 16, 2017
Interrogating open issues in cancer medicine with patient-derived xenografts
Annette T Byrne, Denis G Alférez, Frédéric Amant, et al.
Nature Communications
|
December 23, 2021
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma
Joris L Vos, Joris B W Elbers, Oscar Krijgsman, et al.
The Lancet. Oncology
|
June 5, 2019
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial
Elisa A Rozeman, Alexander M Menzies, Alexander C J van Akkooi, et al.
Cancer Research
|
November 3, 2017
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models
Terrence F Meehan, Nathalie Conte, Theodore Goldstein, et al.
Science (New York, N.Y.)
|
May 30, 2020
The human tumor microbiome is composed of tumor type-specific intracellular bacteria
Deborah Nejman, Ilana Livyatan, Garold Fuks, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 117) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 117 results.
Cancer Cell
|
March 15, 2024
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness
Chun-Pu Lin, Pierre L Levy, Astrid Alflen, et al.
Nature Reviews. Cancer
|
January 21, 2017
Interrogating open issues in cancer precision medicine with patient-derived xenografts
Annette T Byrne, Denis G Alférez, Frédéric Amant, et al.
Nature Reviews. Cancer
|
September 16, 2017
Interrogating open issues in cancer medicine with patient-derived xenografts
Annette T Byrne, Denis G Alférez, Frédéric Amant, et al.
Nature Communications
|
December 23, 2021
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma
Joris L Vos, Joris B W Elbers, Oscar Krijgsman, et al.
The Lancet. Oncology
|
June 5, 2019
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial
Elisa A Rozeman, Alexander M Menzies, Alexander C J van Akkooi, et al.
Cancer Research
|
November 3, 2017
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models
Terrence F Meehan, Nathalie Conte, Theodore Goldstein, et al.
Science (New York, N.Y.)
|
May 30, 2020
The human tumor microbiome is composed of tumor type-specific intracellular bacteria
Deborah Nejman, Ilana Livyatan, Garold Fuks, et al.
Page
of 12